Related Experiment Video

Updated: Jun 14, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus

Mohamed L Salem1, Maha El-Demellawy, Abdel Raouf Abou El-Azm

  • 1Surgery Department and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA. mohamedlabibsalem@yahoo.com

Cellular Immunology
|March 27, 2010
PubMed

Insights

Chronic Hepatitis C virus (HCV) infection may stem from immune system dysfunction. Restoring immune balance using agents like Toll-like receptor agonists could help clear the virus.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection affects millions globally, leading to chronic illness, cirrhosis, and liver cancer.
  • Current treatments like pegylated interferon-alpha (IFN-alpha) and ribavirin have limitations, with many patients failing therapy.
  • The failure to resolve HCV infection is linked to impaired anti-HCV immunity.

Purpose of the Study:

  • To explore the mechanisms behind dysfunctional anti-HCV immunity in chronic infection.
  • To hypothesize that an imbalance between immunosuppressive and stimulatory immune cells contributes to persistent HCV.
  • To review potential therapeutic strategies targeting this immune imbalance.

Main Methods:

  • Review of existing literature on HCV immunology and treatment failure.
  • Hypothesizing the role of regulatory cells, dendritic cells (DCs), and natural killer (NK) cells in chronic HCV.
  • Focusing on Toll-like receptor (TLR) agonists as potential therapeutic agents.

Main Results:

  • Chronic HCV infection is associated with an increase in immunosuppressive cells.
  • A decrease in stimulatory dendritic cells (DCs) and natural killer (NK) cells is observed in chronic HCV patients.
  • This immune dysregulation hinders the body's ability to clear the virus.

Conclusions:

  • Dysfunctional anti-HCV immunity, characterized by an imbalance of immune cells, is a key factor in persistent infection.
  • Therapeutic strategies aimed at restoring immune balance, such as using TLR agonists, hold promise for treating chronic HCV.
  • Targeting regulatory and stimulatory immune cells could lead to viral clearance and improved patient outcomes.

More Related Videos

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...